Wolverine Trading’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11.7M | Buy |
43,100
+2,700
| +7% | +$735K | 0.01% | 849 |
|
|
2025
Q2 | $11.1M | Buy |
+40,400
| New | +$11M | 0.01% | 669 |
|
|
2025
Q1 | – | Sell |
-47,000
| Closed | -$10.9M | – | 4862 |
|
|
2024
Q4 | $10.9M | Buy |
47,000
+7,500
| +19% | +$1.72M | 0.01% | 737 |
|
|
2024
Q3 | $8.62M | Buy |
39,500
+17,400
| +79% | +$3.6M | 0.01% | 762 |
|
|
2024
Q2 | $4.34M | Buy |
22,100
+3,200
| +17% | +$661K | ﹤0.01% | 1062 |
|
|
2024
Q1 | $4.07M | Sell |
18,900
-38,500
| -67% | -$8.09M | ﹤0.01% | 1142 |
|
|
2023
Q4 | $12.1M | Buy |
57,400
+13,400
| +30% | +$2.86M | 0.01% | 638 |
|
|
2023
Q3 | $8.81M | Buy |
44,000
+10,700
| +32% | +$2.13M | 0.01% | 677 |
|
|
2023
Q2 | $6.11M | Buy |
33,300
+5,800
| +21% | +$1.07M | 0.01% | 810 |
|
|
2023
Q1 | $5.2M | Buy |
27,500
+1,500
| +6% | +$271K | 0.01% | 826 |
|
|
2022
Q4 | $4.37M | Sell |
26,000
-12,100
| -32% | -$2.1M | 0.01% | 969 |
|
|
2022
Q3 | $6.81M | Sell |
38,100
-4,900
| -11% | -$968K | 0.01% | 713 |
|
|
2022
Q2 | $8.86M | Buy |
43,000
+13,600
| +46% | +$2.88M | 0.01% | 562 |
|
|
2022
Q1 | $7.11M | Sell |
29,400
-17,900
| -38% | -$4.2M | 0.01% | 875 |
|
|
2021
Q4 | $10.8M | Sell |
47,300
-4,300
| -8% | -$946K | 0.01% | 697 |
|
|
2021
Q3 | $10.1M | Buy |
51,600
+9,500
| +23% | +$1.92M | 0.01% | 792 |
|
|
2021
Q2 | $8.98M | Hold |
42,100
| – | – | 0.01% | 749 |
|
|
2021
Q1 | $8.63M | Sell |
42,100
-25,300
| -38% | -$4.98M | 0.01% | 779 |
|
|
2020
Q4 | $12M | Sell |
67,400
-16,400
| -20% | -$2.79M | 0.02% | 601 |
|
|
2020
Q3 | $13.9M | Sell |
83,800
-40,100
| -32% | -$6.75M | 0.03% | 415 |
|
|
2020
Q2 | $20.1M | Sell |
123,900
-7,300
| -6% | -$1.31M | 0.05% | 252 |
|
|
2020
Q1 | $22.8M | Sell |
131,200
-6,200
| -5% | -$1.23M | 0.07% | 195 |
|
|
2019
Q4 | $27.4M | Sell |
137,400
-34,900
| -20% | -$7.16M | 0.07% | 250 |
|
|
2019
Q3 | $36.9M | Buy |
172,300
+21,700
| +14% | +$4.53M | 0.11% | 140 |
|
|
2019
Q2 | $29.2M | Buy |
150,600
+46,500
| +45% | +$8.57M | 0.08% | 194 |
|
|
2019
Q1 | $17.1M | Buy |
+104,100
| New | +$18.4M | 0.05% | 312 |
|
|
2018
Q4 | – | Sell |
-79,900
| Closed | -$13.6M | – | 4527 |
|
|
2018
Q3 | $13.6M | Buy |
79,900
+4,400
| +6% | +$741K | 0.03% | 433 |
|
|
2018
Q2 | $12.2M | Hold |
75,500
| – | – | 0.03% | 415 |
|
|
2018
Q1 | $12.2M | Sell |
75,500
-35,800
| -32% | -$5.7M | 0.03% | 415 |
|
|
2017
Q4 | $16.3M | Buy |
111,300
+35,000
| +46% | +$4.98M | 0.06% | 299 |
|
|
2017
Q3 | $10.4M | Buy |
+76,300
| New | +$9.64M | 0.04% | 417 |
|
|
2017
Q2 | – | Sell |
-41,000
| Closed | -$4.87M | – | 4328 |
|
|
2017
Q1 | $4.87M | Sell |
41,000
-30,900
| -43% | -$3.72M | 0.03% | 662 |
|
|
2016
Q4 | $8.29M | Sell |
71,900
-29,900
| -29% | -$3.33M | 0.04% | 458 |
|
|
2016
Q3 | $10.7M | Sell |
101,800
-7,400
| -7% | -$773K | 0.05% | 416 |
|
|
2016
Q2 | $10.5M | Buy |
+109,200
| New | +$10.3M | 0.06% | 335 |
|
Other funds holding CME
Wolverine Trading's CME Position: Q3 2025 in Review
Wolverine Trading increased its CME Group (CME) stake by 113% in Q3 2025, buying an estimated $634K and bringing the position to 4,397 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2717.
Wolverine Trading first reported a position in CME in Q3 2016 and has held it in 27 quarters since. The position peaked at $26.1M in Q4 2019. 1,650 funds tracked by Wall St. Rank hold CME as of Q3 2025.
- Wolverine Trading held 4,397 shares of CME Group worth $1.2M as of Q3 2025.
- Wolverine Trading bought 2,331 CME Group shares in Q3 2025, an estimated $634K.
- CME Group made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2717 holding.
- Wolverine Trading first reported a position in CME Group in Q3 2016 and has held it in 27 quarters since.
- Wolverine Trading's CME Group position peaked at $26.1M in Q4 2019.
- 1,650 funds tracked by Wall St. Rank held CME Group as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.